OMX Copenhagen 20
1.753,89
PKT
+2,63
PKT
+0,15
%
Werbung
Analysen zu OMX Copenhagen 20-Werten
Datum | Rating | Analyst | |
---|---|---|---|
09.06.16 | Novo Nordisk overweight | Morgan Stanley | |
09.06.16 | Novo Nordisk buy | Baader Wertpapierhandelsbank | |
26.05.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
26.05.16 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
23.05.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
06.05.16 | Novo Nordisk Hold | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
04.05.16 | Novo Nordisk buy | Citigroup Corp. | |
03.05.16 | Novo Nordisk Halten | Independent Research GmbH | |
03.05.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
02.05.16 | Novo Nordisk overweight | Barclays Capital | |
29.04.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
26.04.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
22.04.16 | Novo Nordisk overweight | Morgan Stanley | |
18.04.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
11.04.16 | Novo Nordisk Hold | Deutsche Bank AG | |
29.03.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
22.03.16 | Novo Nordisk overweight | Morgan Stanley | |
15.03.16 | Novo Nordisk Hold | Jefferies & Company Inc. | |
07.03.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
07.03.16 | Novo Nordisk overweight | Morgan Stanley | |
07.03.16 | Novo Nordisk Sell | UBS AG | |
07.03.16 | Novo Nordisk buy | Citigroup Corp. | |
07.03.16 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
02.03.16 | Novo Nordisk buy | Citigroup Corp. | |
24.02.16 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
24.02.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
22.02.16 | Novo Nordisk Hold | Jefferies & Company Inc. | |
16.02.16 | Novo Nordisk Neutral | BNP PARIBAS | |
15.02.16 | Novo Nordisk Conviction Buy List | Goldman Sachs Group Inc. | |
09.02.16 | Novo Nordisk Halten | Independent Research GmbH | |
08.02.16 | Novo Nordisk Sell | UBS AG | |
04.02.16 | Novo Nordisk overweight | Barclays Capital | |
04.02.16 | Novo Nordisk Neutral | UBS AG | |
04.02.16 | Novo Nordisk overweight | JP Morgan Chase & Co. | |
03.02.16 | Novo Nordisk verkaufen | S&P Capital IQ | |
01.02.16 | Novo Nordisk buy | Goldman Sachs Group Inc. | |
01.02.16 | Novo Nordisk buy | Citigroup Corp. | |
01.02.16 | Novo Nordisk overweight | Morgan Stanley | |
01.02.16 | Novo Nordisk Neutral | UBS AG | |
01.02.16 | Novo Nordisk overweight | JP Morgan Chase & Co. |